294 related articles for article (PubMed ID: 7923141)
21. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
22. A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III.
Avivi A; Yayon A; Givol D
FEBS Lett; 1993 Sep; 330(3):249-52. PubMed ID: 8375495
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
24. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of fibroblast growth factor 8 in human breast cancer.
Marsh SK; Bansal GS; Zammit C; Barnard R; Coope R; Roberts-Clarke D; Gomm JJ; Coombes RC; Johnston CL
Oncogene; 1999 Jan; 18(4):1053-60. PubMed ID: 10023681
[TBL] [Abstract][Full Text] [Related]
27. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer.
Zammit C; Barnard R; Gomm J; Coope R; Shousha S; Coombes C; Johnston C
J Pathol; 2001 May; 194(1):27-34. PubMed ID: 11329138
[TBL] [Abstract][Full Text] [Related]
28. Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.
Kettunen P; Karavanova I; Thesleff I
Dev Genet; 1998; 22(4):374-85. PubMed ID: 9664689
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 1-IIIb is dispensable for skin morphogenesis and wound healing.
Zhang H; Dessimoz J; Beyer TA; Krampert M; Williams LT; Werner S; Grose R
Eur J Cell Biol; 2004 Feb; 83(1):3-11. PubMed ID: 15085950
[TBL] [Abstract][Full Text] [Related]
30. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
Chen G; Wang J; Liu Z; Kornmann M
Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
[TBL] [Abstract][Full Text] [Related]
31. The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.
Scotet E; Houssaint E
Biochim Biophys Acta; 1995 Nov; 1264(2):238-42. PubMed ID: 7495869
[TBL] [Abstract][Full Text] [Related]
32. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
34. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
Cha JY; Lambert QT; Reuther GW; Der CJ
Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
[TBL] [Abstract][Full Text] [Related]
35. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
Adar R; Monsonego-Ornan E; David P; Yayon A
J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
[TBL] [Abstract][Full Text] [Related]
36. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.
Wu R; Connolly D; Ngelangel C; Bosch FX; Muñoz N; Cho KR
Oncogene; 2000 Nov; 19(48):5543-6. PubMed ID: 11114733
[TBL] [Abstract][Full Text] [Related]
38. Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.
Yagasaki F; Wakao D; Yokoyama Y; Uchida Y; Murohashi I; Kayano H; Taniwaki M; Matsuda A; Bessho M
Cancer Res; 2001 Dec; 61(23):8371-4. PubMed ID: 11731410
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain.
Beer HD; Vindevoghel L; Gait MJ; Revest JM; Duan DR; Mason I; Dickson C; Werner S
J Biol Chem; 2000 May; 275(21):16091-7. PubMed ID: 10821861
[TBL] [Abstract][Full Text] [Related]
40. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
Tannheimer SL; Rehemtulla A; Ethier SP
Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
